Zekel Healthcare ^Company

The Alzheimer’s disease market is further segmented by geographical region as North America which includes The USA and Canada, Latin American countries such as Brazil, Argentina, Colombia, European countries such as The UK, France, Germany, Italy, Asia-Pacific countries such as Japan, China, India and Australia and for Middle East & Africa countries are Saudi Arabia, UAE, Qatar and South Africa. The economic and social impact of chronic brain disorders (CBD) such as Alzheimer's disease (AD) and other neurodegenerative diseases will become the number one public health problem worldwide, directly affecting 100 million people by 2050. On-going demographic trends, namely ageing populations worldwide, are leading to the unprecedented expansion of consumer demand for healthcare services. Healthcare systems worldwide soon will confront a serious crisis as a result of significant growth of the healthcare market